OTCMKTS:FFNTF

4Front Ventures Stock Forecast, Price & News

$1.24

+0.05 (+4.20 %)

(As of 04/19/2021 12:00 AM ET)

Add

Compare

Today's Range

$1.14

Now: $1.24▼

$1.24

50-Day Range

$1.08

MA: $1.31▼

$1.68

52-Week Range

$0.20

Now: $1.24▼

$1.98

Volume774,107 shs

Average Volume1.43 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. It operates through Retail, Production, Pure Ratios, and Real Estate segments. The company produces and sells cannabis and CBD. As of December 31, 2019, it operated 11 dispensaries in Massachusetts, Illinois, Maryland, Michigan, Pennsylvania, Arkansas, and Arizona. In addition, the company sells supplies to cannabis producers, as well as non-TCH products; imports equipment and supplies for resale; leases real estate properties; offers consulting services; and operates cannabis dispensaries. 4Front Ventures Corp. was founded in 2011 and is headquartered in Phoenix, Arizona.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers—Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:FFNTF

Previous Symbol

CUSIPN/A

CIKN/A

Web4frontventures.com

Phone602 633 3067

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Headlines

4Front Ventures Corp. (OTCMKTS:FFNTF) Sees Large Growth in Short Interest
April 15, 2021 | americanbankingnews.com

Cannabis Industry Investor Conference: Company Executives Present April 20th
April 14, 2021 | finance.yahoo.com

4Front Ventures Corp - Ordinary Shares (Sub Voting) to Host Earnings Call
April 6, 2021 | finance.yahoo.com

4Front Announces Fourth Quarter and Fiscal Year 2020 Results and Provides Business Update
April 6, 2021 | finance.yahoo.com

4Front Ventures Announces Conference Participation for April 2021
April 5, 2021 | finance.yahoo.com

4Front Ventures Corp. (OTCMKTS:FFNTF) Short Interest Update
April 1, 2021 | americanbankingnews.com

Schneider Electric Once Again on the 2021 Carbon Clean 200™ List Showing the Way to a Clean Energy Future
February 19, 2021 | finance.yahoo.com

Media Advisory - Prime Minister's itinerary for Friday, February 5, 2021
February 4, 2021 | finance.yahoo.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1918th out of 2,018 stocks

Drug Manufacturers—Specialty & Generic Industry

63rd out of 81 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for 4Front Ventures.

0.0 Community Rank

Outperform Votes
4Front Ventures has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
4Front Ventures has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about 4Front Ventures and other stocks. Vote “Outperform” if you believe FFNTF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FFNTF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
4Front Ventures does not currently pay a dividend.
Dividend Growth
4Front Ventures does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 4Front Ventures insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$1.24

+0.05 (+4.20 %)

(As of 04/19/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive FFNTF News and Ratings via Email

Sign-up to receive the latest news and ratings for FFNTF and its competitors with MarketBeat's FREE daily newsletter.

4Front Ventures (OTCMKTS:FFNTF) Frequently Asked Questions

What stocks does MarketBeat like better than 4Front Ventures?

Wall Street analysts have given 4Front Ventures a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 4Front Ventures wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting 4Front Ventures?

4Front Ventures saw a increase in short interest in March. As of March 31st, there was short interest totaling 196,800 shares, an increase of 102.5% from the March 15th total of 97,200 shares. Based on an average daily trading volume, of 1,924,400 shares, the short-interest ratio is currently 0.1 days.
View 4Front Ventures' Short Interest.

Who are 4Front Ventures' key executives?

4Front Ventures' management team includes the following people:

Mr. Joshua Nathaniel Rosen, Exec. Chairman (Age 48, Pay $371.61k)
Mr. Leonid Gontmakher, CEO & Not Independent Director (Age 35, Pay $166.67k)
Mr. Kristopher Tutundjian Krane, Pres
Mr. Trevor John Pratte, Sec. (Age 42, Pay $192.15k)
Ms. Nicolle Dorsey, Chief Financial Officer (Age 43)
Mr. Joseph R. Feltham, Chief Operating Officer
Mr. Andrew Fisher Thut, Chief Investment Officer
Clay Crolius, Principal Accounting Officer & Controller
Dr. David Nathan M.D., Chief Medical Advisor
Ms. Leah Heise, Chief Experience Officer

Who are some of 4Front Ventures' key competitors?

Some companies that are related to 4Front Ventures include (CSI) (CSI), 1933 Industries (TGIFF), 28896 (BAMM), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRHF), Acreage (ACRDF), AFT Pharmaceuticals (AFP), Agraflora Organics International (AGRA), AgraFlora Organics International (AGFAF), Aleafia Health (ALEAF), American Green (ERBB), Australian Primary Hemp (APH), Ayr Wellness (AYRWF) and Benchmark (BHCCF).
View all of FFNTF's competitors.

What is 4Front Ventures' stock symbol?

4Front Ventures trades on the OTCMKTS under the ticker symbol "FFNTF."

How do I buy shares of 4Front Ventures?

Shares of FFNTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 4Front Ventures' stock price today?

One share of FFNTF stock can currently be purchased for approximately $1.24.

What is 4Front Ventures' official website?

The official website for 4Front Ventures is 4frontventures.com.

How can I contact 4Front Ventures?

The company can be reached via phone at 602 633 3067.

This page was last updated on 4/20/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

4Front Ventures Stock Forecast, Price & News

Adding

Adding

Adding 4Front Ventures Corp.

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Headlines

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes